NexgenRX Inc. (NXG) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.106x

Based on the latest financial reports, NexgenRX Inc. (NXG) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$880.82K ≈ $637.17K USD) by net assets (CA$8.29 Million ≈ $6.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NexgenRX Inc. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how NexgenRX Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NexgenRX Inc. (NXG) financial obligations for a breakdown of total debt and financial obligations.

NexgenRX Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexgenRX Inc. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Genus PLC LSE:GNS	0.100x
Blender Financial Technologies Ltd TA:BLND	-0.042x
Epsium Enterprise Limited Ordinary Shares NASDAQ:EPSM	N/A
CNFinance Holdings Ltd NYSE:CNF	-0.011x
Austin Gold Corp NYSE MKT:AUST	-0.013x
Medifron DBT Co. Ltd KQ:065650	-0.472x
Ozaurum Resources Ltd AU:OZM	-0.323x
Cocrystal Pharma Inc NASDAQ:COCP	-0.274x

Annual Cash Flow Conversion Efficiency for NexgenRX Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of NexgenRX Inc. from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see how much is NexgenRX Inc. worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$7.62 Million ≈ $5.52 Million	CA$1.15 Million ≈ $832.04K	0.151x	-8.88%
2023-12-31	CA$7.71 Million ≈ $5.58 Million	CA$1.28 Million ≈ $924.01K	0.166x	+37.46%
2022-12-31	CA$8.85 Million ≈ $6.40 Million	CA$1.07 Million ≈ $771.17K	0.120x	-69.41%
2021-12-31	CA$9.71 Million ≈ $7.03 Million	CA$3.82 Million ≈ $2.77 Million	0.394x	-18.05%
2020-12-31	CA$5.52 Million ≈ $3.99 Million	CA$2.65 Million ≈ $1.92 Million	0.480x	-15.42%
2019-12-31	CA$1.84 Million ≈ $1.33 Million	CA$1.05 Million ≈ $756.44K	0.568x	+319.14%
2018-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-507.38K ≈ $-367.03K	-0.259x	-97.65%
2017-12-31	CA$1.96 Million ≈ $1.42 Million	CA$-257.35K ≈ $-186.16K	-0.131x	-120.25%
2016-12-31	CA$758.06K ≈ $548.37K	CA$490.96K ≈ $355.16K	0.648x	+55.58%
2015-12-31	CA$-83.93K ≈ $-60.71K	CA$-34.94K ≈ $-25.27K	0.416x	-65.35%
2014-12-31	CA$-464.55K ≈ $-336.05K	CA$-558.18K ≈ $-403.78K	1.202x	+105.71%
2013-12-31	CA$-36.81K ≈ $-26.63K	CA$774.08K ≈ $559.95K	-21.026x	--

About NexgenRX Inc.

V:NXG Canada Health Information Services

Market Cap

$19.03 Million

CA$26.31 Million CAD

Market Cap Rank

#25175 Global

#994 in Canada

Share Price

CA$0.37

Change (1 day)

+2.78%

52-Week Range

CA$0.28 - CA$0.43

All Time High

CA$0.43